Search

The article discusses a case study involving a 12-year-old boy with a novel SCN1A mutation presenting as hyperkinetic movement disorder, including multifocal dystonia and parakinesia, without seizures. It mentions that this unique presentation underscores the importance of genetic evaluation and individualized management approaches for patients with SCN1A mutations, leading to improved clinical outcomes.